Concentrix Corp — Director's Dealing 2020

Dec 8, 2020

SEC Form 4/A — Form 4/A

Issuer: Concentrix Corp (CNXC)
CIK: 0001803599
Period of Report: 2020-12-01

Reporting Person: Caldwell Christopher A (Director, President and CEO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-12-01	Employee Stock Option (Right to Buy)	$31.39	J	12928	Acquired	2024-10-07	Common Stock (12928.0)	Direct
2020-12-01	Employee Stock Option (Right to Buy)	$44.52	J	9363	Acquired	2025-10-06	Common Stock (9363.0)	Direct
2020-12-01	Employee Stock Option (Right to Buy)	$55.94	J	12630	Acquired	2026-10-04	Common Stock (12630.0)	Direct
2020-12-01	Employee Stock Option (Right to Buy)	$64.21	J	11172	Acquired	2027-10-03	Common Stock (11172.0)	Direct
2020-12-01	Employee Stock Option (Right to Buy)	$37.94	J	45808	Acquired	2028-10-11	Common Stock (45808.0)	Direct
2020-12-01	Employee Stock Option (Right to Buy)	$55.12	J	30057	Acquired	2029-10-02	Common Stock (30057.0)	Direct

Footnotes

F1: In connection with the spin-off of Concentrix Corporation ("Concentrix") by SYNNEX Corporation ("SYNNEX") and pursuant to the employee matters agreement between SYNNEX and Concentrix, on December 1, 2020, each outstanding option to purchase SYNNEX common stock was converted into a stock option to purchase SYNNEX common stock and a stock option to purchase Concentrix common stock, in each case with respect to the same number of shares as the original SYNNEX stock option. The exercise price of the converted Concentrix stock option was determined on December 4, 2020 in accordance with the terms of the employee matters agreement. This Form 4/A is being filed to report the adjusted exercise price.

F2: The converted Concentrix stock option has the same vesting schedule as the original SYNNEX stock option, which vested as to 20% of the shares on October 4, 2017, the first anniversary of the date of grant, and vests as to 1/60th of the shares monthly thereafter.

F3: The converted Concentrix stock option has the same vesting schedule as the original SYNNEX stock option, which vested as to 20% of the shares on October 3, 2018, the first anniversary of the date of grant, and vests as to 1/60th of the shares monthly thereafter.

F4: The converted Concentrix stock option has the same vesting schedule as the original SYNNEX stock option, which vested as to 20% of the shares on October 11, 2019, the first anniversary of the date of grant, and vests as to 1/60th of the shares monthly thereafter.

F5: The converted Concentrix stock option has the same vesting schedule as the original SYNNEX stock option, which vested as to 20% of the shares on October 2, 2020, the first anniversary of the date of grant, and vests as to 1/60th of the shares monthly thereafter.